We are live on ! Find out more
EA

Emerald Advisers Portfolio holdings

AUM $3.16B
1-Year Est. Return 109.58%
This Fund
S&P 500
This Quarter Est. Return
+36.72%
1 Year Est. Return
+109.58%
3 Year Est. Return
+352.93%
5 Year Est. Return
+451.34%
10 Year Est. Return
+3,577.15%
AUM
$3.01B
AUM Growth
+$583M
Cap. Flow
-$32.3M
Cap. Flow %
-1.07%
Top 10 Hldgs %
19.61%
Holding
374
New
40
Increased
94
Reduced
116
Closed
88

Top Buys

Rank Stock Value
1
RARE icon
Ultragenyx Pharmaceutical
RARE
+$26.9M
2
EBC icon
Eastern Bankshares
EBC
+$24.9M
3
MAX icon
MediaAlpha
MAX
+$21.2M
4
HLI icon
Houlihan Lokey
HLI
+$19.7M
5
ALGM icon
Allegro MicroSystems
ALGM
+$18.9M

Top Sells

Rank Stock Value
1
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
+$43.8M
2
BLD
TopBuild
BLD
+$38.3M
3
TWST icon
Twist Bioscience
TWST
+$28.8M
4
QTS
QTS REALTY TRUST, INC.
QTS
+$25M
5
PS
Pluralsight, Inc. Class A Common Stock
PS
+$24.1M

Sector Composition

Rank Sector Weight
1 Healthcare 23.28%
2 Technology 20.52%
3 Consumer Discretionary 15.17%
4 Industrials 13.7%
5 Financials 8.68%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PAG icon
326
Penske Automotive Group
PAG
$14.2B
– –
-317
Closed -$15K
PEN icon
327
Penumbra
PEN
$12.6B
– –
-2,902
Closed -$564K
PINE
328
Alpine Income Property Trust
PINE
$341M
– –
-658
Closed -$10K
PLAB icon
329
Photronics
PLAB
$1.76B
– –
-1,348
Closed -$13K
PLYM
330
DELISTED
Plymouth Industrial REIT
PLYM
– –
-1,157
Closed -$14K
PMT
331
PennyMac Mortgage Investment
PMT
$839M
– –
-1,669
Closed -$27K
PSN icon
332
Parsons
PSN
$6.36B
– –
-383
Closed -$13K
PSTL
333
Postal Realty Trust
PSTL
$722M
– –
-1,065
Closed -$16K
REGN icon
334
Regeneron Pharmaceuticals
REGN
$69.9B
– –
-557
Closed -$312K
RKT icon
335
Rocket Companies
RKT
$38.2B
– –
-74,721
Closed -$1.49M
RYN icon
336
Rayonier
RYN
$6.52B
– –
-696
Closed -$17K
SAFE
337
Safehold
SAFE
$1.19B
– –
-241
Closed -$14K
SAIC icon
338
Saic
SAIC
$5.01B
– –
-293,293
Closed -$23M
SNEX icon
339
StoneX
SNEX
$9B
– –
-1,296
Closed -$13K
STAG icon
340
STAG Industrial
STAG
$7.77B
– –
-740
Closed -$23K
STBA icon
341
S&T Bancorp
STBA
$1.88B
– –
-1,000
Closed -$18K
STC icon
342
Stewart Information Services
STC
$2.02B
– –
-339
Closed -$15K
SWBI icon
343
Smith & Wesson
SWBI
$666M
– –
-1,236
Closed -$19K
TBBK icon
344
The Bancorp
TBBK
$2.81B
– –
-1,503
Closed -$13K
TDC icon
345
Teradata
TDC
$2.8B
– –
-518
Closed -$12K
UFPI icon
346
UFP Industries
UFPI
$4.98B
– –
-294
Closed -$17K
VMC icon
347
Vulcan Materials
VMC
$36.9B
– –
-10,169
Closed -$1.38M
VYX icon
348
NCR Voyix
VYX
$1.13B
– –
-1,148
Closed -$16K
WAB icon
349
Wabtec
WAB
$50.8B
– –
-1,100
Closed -$68K
WAL icon
350
Western Alliance Bancorporation
WAL
$9.04B
– –
-6,526
Closed -$206K
11 12 13
14
15

Similar funds

FTUS
Flow Traders U.S. New York $3.16B AUM 19.52% 1-Year Est. Return
BFA
Bragg Financial Advisors Charlotte, North Carolina $3.16B AUM 26% 1-Year Est. Return
BP
BNP Paribas Paris, France $3.15B AUM 22.54% 1-Year Est. Return
CVA
Ceredex Value Advisors Orlando, Florida $3.18B AUM 35.23% 1-Year Est. Return
DWP
Daymark Wealth Partners Cincinnati, Ohio $3.18B AUM 23.46% 1-Year Est. Return
GKWIM
Gerber Kawasaki Wealth & Investment Management Santa Monica, California $3.14B AUM 22.62% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
FAM
Foxhaven Asset Management Charlottesville, Virginia $3.19B AUM 12.34% 1-Year Est. Return

Emerald Advisers's Q4 2020 Portfolio in Review

As of Q4 2020, Emerald Advisers held 374 positions worth $3.01B, up 24% from $2.43B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Emerald Advisers's Q4 2020 filing shows 40 new, 94 increased, 116 reduced and 88 closed positions. Its largest new stake was Ultragenyx Pharmaceutical: 226,875 shares worth $31.4M. The largest sale was Horizon Therapeutics Public Limited Company Ordinary Shares, an estimated $43.8M.

By sector, the portfolio is most concentrated in Healthcare at 23% of assets, up from 21% a quarter earlier, followed by Technology and Consumer Discretionary.

  • Emerald Advisers's largest Q4 2020 buy was Ultragenyx Pharmaceutical: 226,875 shares worth $31.4M.
  • Emerald Advisers added most to Arena Pharmaceuticals Inc in Q4 2020, an estimated $18.6M increase.
  • Emerald Advisers's biggest Q4 2020 reduction was Horizon Therapeutics Public Limited Company Ordinary Shares, cutting an estimated $43.8M.
  • Emerald Advisers fully exited Pluralsight, Inc. Class A Common Stock in Q4 2020, selling an estimated $24.1M.
  • Emerald Advisers's ten largest holdings make up 20% of its $3.01B portfolio in Q4 2020.
  • Emerald Advisers opened 40 new positions and closed 88 in Q4 2020.
  • Emerald Advisers's portfolio value rose 24% quarter-over-quarter to $3.01B.

Based on Emerald Advisers's 13F filing for Q4 2020, filed 29 Jan 2021.